10-Q quarterly report · filed Oct 29, 2026

Exelixis Inc (EXEL) Q4 2026 10-Q Quarterly Report

Short answer

Exelixis Inc (EXEL) filed its Q4 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Oct 2, 2026. Quarterly revenue was $659M (up 10.2% year over year) with net income of $218M.

Q4 2026 key financials · XBRL

Revenue
$659M
+10.2% YoY · +4.8% QoQ
Net income
$218M
+12.7% YoY · +2.9% QoQ
Operating margin
40.8%
EPS (diluted)
$0.86
+22.9% YoY · +6.2% QoQ

Source: XBRL data from the Exelixis Inc (EXEL) Q4 2026 10-Q on SEC EDGAR. USD.

Exelixis Inc Q4 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Total revenue $658.7M vs $597.8M YoY, up $60.9M
  • Net income $218.1M vs $193.6M YoY, with effective tax rate 22.9% vs 23.3%
  • Best product CABOMETYX revenue $603.2M vs $539.9M, up $63.3M
  • Cash, equivalents and securities $1.4B vs $1.7B at December 31, 2025
  • Operating cash flow $839.5M, stock repurchases $402.1M through September 30, 2026
  • Outlook: revenue may increase, while reimbursement pressure, tariffs and generic competition remain headwinds

Risk Factors

  • No material changes to risk factors disclosed in Fiscal 2025 Form 10-K
  • Carried-forward business risk: unidentified or currently immaterial risks may impair operations
  • Carried-forward financial risk: existing risks could materially adversely affect financial condition and results of operations

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Exelixis Inc quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.